Clinical Trial Update: Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated combination chemotherapy with or without rituximab in stage III-IV Classic Hodgkin Lymphoma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Classic Hodgkin Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Classic Hodgkin Lymphoma, Lugano Classification Stage III Hodgkin Lymphoma AJCC v8 | Phase 2 | Status: COMPLETED | Results posted: 2020-02-28